Fantastic news.
Trial has finished ahead of time which is virtually unheard of in biotech.
Mid August results due.
I have been invested since IPO and it has gone from studies to Phase 1 to Phase 2 in 3 years. Plenty of other drug bios would still be on Phase 1. Tremendous work by Liz and the team.
Ann: Last Patient Dosed in Phase 2 Stroke Trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
69.5¢ |
Change
0.010(1.46%) |
Mkt cap ! $89.27M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.0¢ | 68.5¢ | $211.2K | 303.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40343 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 8000 | 1 |
View Market Depth
| Last trade - 15.54pm 08/08/2025 (20 minute delay) ? |
| AGN (ASX) Chart |